Abstract:Using an immunogenic nonmetastatic murine mammary adenocarci- noma (Dl-DMBA-3) induced in BALB/c mice by dimethylbenzanthra- cene, we have previously shown that splenocytes from tumor bearers have depressed lymphocyte responses to mitogens and antigens, including tumor-associated antigens. In addition, they display decreased natural killer and T-cell cytotoxic activities. Macrophages from tumor-bearing mice appear to be responsible for the suppression of T- and B-cell responses to concanavalin A, lipopolysaccharide, and tumor-associated antigens observed in tumor bearers. The appearance of these macro phages in the spleen tightly parallels the progressive growth of the tumor and the concomitant immunosuppression. Simultaneously high levels of macrophage progenitors were observed in blood, bone marrow, lung, and liver. A significant increase of colony-stimulating activity of the granu- locyte-macrophage lineage was detected in the sera from tumor-bearing mice. Higher levels of this colony-stimulating activity (CSA) were de tected in tumor cystic fluid as compared with the levels in serum. A tumor cell line established in vitro from the Dl-DMBA-3 in vivotumor produces high levels of a factor with CSA in culture supernatant fluids. Partial purification of the CSA from the tumor cell line supernatants was achieved using Centriceli Ultrafiltration and Sephacryl S-300 chromatog- raphy. These studies revealed that the molecular weight of the colony- stimulating-like factor is 32,000 to 35,000. The morphology of the colonies obtained in cultures using this factor is similar to that of the colonies that develop in the presence of granulocyte-macrophage colony- stimulating factor (GM-CSF) but not with macrophage colony-stimulat ing factor (M-CSF). CSA from tumor cell supernatants was neutralized by antiserum to GM-CSF but not with anti-M-CSF or anti-granulocyte colony-stimulating factor (G-CSF). Macrophages from bone marrow or peritoneal exÃºdalesfrom normal mice cultured with tumor supernatant for 2 to 3 days strongly inhibit normal splenocyte responses to concana valin A and lipopolysaccharide. The data suggest that the tumor releases a GM-CSF that alters the hemopoietic system and induces or expands macrophages, which exert a suppressive function on the immune system of tumor-bearing mice. presser functions appear to play important roles in the regulation of a great variety of in vivo and in vitro immunolog- ical phenomena (1-7). Exactly how those cells are induced and/ or expanded in the tumor-bearing host has not been clearly elucidated. Moreover, it is not known whether tumor products and/or host products directly or indirectly cause the observed immunosuppression. Using an immunogenic nonmetastatic murine mammary ad- enocarcinoma induced in BALB/c mice by dimethylbenzan- thracene (Dl-DMBA-3), we have previously observed a gener alized immunosuppressed state as determined by diminished proliferative responses to mitogens and antigens, decreased natural killer and cytolytic T-lymphocyte activities, and other criteria (8-11). In addition, there is an induction of macro phages in the spleen of tumor bearers which have a Mac 1*2+ phenotype. These macrophages appear to be responsible for the observed immunosuppression via various mechanisms, which include release of prostaglandins and aberrant presentation of antigens in the context of I-E molecules to T-suppressor cells (12). An investigation was undertaken to elucidate the mecha nism of induction of these suppressor macrophages that are in the spleens of mammary tumor-bearing mice. In this paper we present evidence that there is a systemic increase of granulocyte and macrophage progenitors associated with an elevated col ony-stimulating activity in the serum and tumor cystic fluid of tumor bearers. Furthermore, supernatants of tumor cells grown in vitro release high levels of GM-CSF' as defined by bioassays, biochemistry, and neutralization with antiserum to this factor. The results indicate that the tumor constitutively produces GM- CSF, which induces cells of the macrophage lineage that alters nonspecific and specific immune responses in tumor-bearing mice.

ROLE OF TUMOR-DERIVED CYTOKINES ON THE IMMUNE-SYSTEM OF MICE BEARING A MAMMARY ADENOCARCINOMA .2. DOWN-REGULATION OF MACROPHAGE-MEDIATED CYTOTOXICITY BY TUMOR-DERIVED GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR

The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF.

Impaired Activation of Tumoricidal Function in Macrophages from Mammary-Tumor Bearers - the Role of Ifn-Gamma

Decreased Macrophage‐mediated Cytotoxicity in Mammary‐tumor‐bearing Mice is Related to Alteration of Nitric‐oxide Production And/or Release

Expansion Of Immunoregulatory Macrophages By Granulocyte-Macrophage Colony-Stimulating Factor Derived From A Murine Mammary-Tumor

Therapeutic Effect of MIP-1alpha-recruited Dendritic Cells on Preestablished Solid and Metastatic Tumors.

SPLENIC MACROPHAGES FROM TUMOR-BEARING MICE CO-EXPRESSING MAC-1 AND MAC-2 ANTIGENS EXERT IMMUNOREGULATORY FUNCTIONS VIA 2 DISTINCT MECHANISMS

Monocytes Differentiate to Immune Suppressive Precursors of Metastasis-Associated Macrophages in Mouse Models of Metastatic Breast Cancer

Inhibitory Effect of Pyra-Metho-Carnil on the Differentiation and Maturation of Macrophages in Normal and Cancer Microenvironments

GM-CSF derived from the inflammatory microenvironment potentially enhanced PD-L1 expression on tumor-associated macrophages in human breast cancer

Tumor-Associated Macrophages Promote Invasion while Retaining Fc-Dependent Anti-Tumor Function

Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth factor β

Attenuated TGFB signalling in macrophages decreases susceptibility to DMBA-induced mammary cancer in mice

Macrophage depletion decreases inflammation and tumorigenesis in the AOM/DSS mouse model of colon cancer

Immunotherapy of Tumors with Recombinant Adenovirus Encoding Macrophage Inflammatory Protein 3β Induces Tumor-Specific Immune Response in Immunocompetent Tumor-Bearing Mice

Depletion of Tumor-Associated Macrophages Slows the Growth of Chemically Induced Mouse Lung Adenocarcinomas

Thymic Involution And Thymocyte Phenotypic Alterations Induced By Murine Mammary Adenocarcinomas

Effect Of Tumor Cell-Derived Debris And Igg On Metastasis Of Pancreatic Cancer And Inflammation Through Tumor-Associated Macrophages.

Abstract B52: Characterizing the MDSCs phenotypes, expansion, and trafficking pattern and associated tumor-induced immune dysfunction

Redirecting Immune Activation in the Tumor Microenvironment of Estrogen Receptor Negative Breast Cancer

IN VIVO STUDY OF POTENTIAL MECHANISMS OF MACROPHAGE REPOLARIZATION ON THE BACKGROUND OF TUMOR GROWTH